Analysis of the therapeutic effect of comprehensive nursing combined with digital droplet PCR technology on bullous dermatoid diseases
Abstract
Bullous skin disease is an autoimmune disorder characterized by blistering of the skin or mucous membranes that can seriously affect quality of life and health. Similar to studies at the biomolecular (Protein-Protein Interactions Mechanics), cellular (including Cell Membrane Elasticity, Cell Adhesion Mechanics, Cytoskeleton Mechanics, Mechanical Stimuli Response, Cellular Deformation Mechanisms, Intracellular Force Transmission), and tissue levels, the goal of this study is to facilitate more sophisticated monitoring and understanding of disease through the introduction of an advanced diagnostic technique, digital droplet PCR (ddPCR), combined with intensive patient care strategies including health education, emotional support, and personalized health programs. To optimize nursing strategy and improve treatment effect by accurately evaluating the condition. A randomized controlled trial design was used to study 50 patients with bullous skin disease for 12 weeks. The results showed that the overall response rate in the experimental group (comprehensive care combined with ddPCR treatment) was 92%, which was significantly higher than that in the control group (76%) receiving conventional treatment alone. The experimental group showed more significant improvements in reducing the area of skin damage and reducing itching. ddPCR technology shows high sensitivity and specificity in identifying gene mutations associated with bullous skin diseases, providing strong support for individualized treatment. By continuously monitoring disease activity indicators through ddPCR, in relation to Molecular Mechanics and Biomolecular Force Spectroscopy which might be associated with the underlying molecular mechanisms of the disease, we are able to fine-tune treatment strategies, including drug dosage and wound care regimens, to accelerate recovery.
References
1. Ashraf MJ, Shamsizadeh F, Morovati H, et al. Accompanying a semi‐nested PCR assay to support histopathology findings of fungal keratitis in formalin‐fixed paraffin‐embedded corneal samples. Journal of Clinical Laboratory Analysis. 2022; 36(12). doi: 10.1002/jcla.24764
2. Yang Y, Hua C, Liu Y, et al. Droplet digital PCR aids in the diagnosis of children with fever of unknown origin—A typical case report. Heliyon. 2024; 10(10): e30961. doi: 10.1016/j.heliyon.2024.e30961
3. Zhao Y, Xu D, Ke F, et al. A droplet digital PCR method (ddPCR) for sensitive detection and quantification of Carassius auratus herpesvirus (CaHV). Water Biology and Security. 2024; 3(2): 100252. doi: 10.1016/j.watbs.2024.100252
4. Zhou YZ, Zhao YH, Fang WZ, et al. Establishment of droplet digital PCR for the detection of Neisseria gonorrhoeae. Diagnostic Microbiology and Infectious Disease. 2024; 110(1): 116351. doi: 10.1016/j.diagmicrobio.2024.116351
5. Silgado A, Armas M, Sánchez-Montalvá A, et al. Changes in the microbiological diagnosis and epidemiology of cutaneous leishmaniasis in real-time PCR era: A six-year experience in a referral center in Barcelona. Acosta-Serrano A, ed. PLOS Neglected Tropical Diseases. 2021; 15(11): e0009884. doi: 10.1371/journal.pntd.0009884
6. Manta FSdN, Jacomasso T, Rampazzo RdCP, et al. Development and validation of a multiplex real-time qPCR assay using GMP-grade reagents for leprosy diagnosis. Adams LB, ed. PLOS Neglected Tropical Diseases. 2022; 16(2): e0009850. doi: 10.1371/journal.pntd.0009850
7. Haegeman A, De Leeuw I, Philips W, et al. Development and Validation of a New DIVA Real-Time PCR Allowing to Differentiate Wild-Type Lumpy Skin Disease Virus Strains, Including the Asian Recombinant Strains, from Neethling-Based Vaccine Strains. Viruses. 2023; 15(4): 870. doi: 10.3390/v15040870
8. Cao Y, Zhao F, Feng P, et al. Stem-loop RT-qPCR system for multiplex miRNA profiling and its application in wound healing-specific biomarker identification. Analytical Biochemistry. 2023; 678: 115267. doi: 10.1016/j.ab.2023.115267
9. Agianniotaki EI, Chaintoutis SC, Haegeman A, et al. A TaqMan probe-based multiplex real-time PCR method for the specific detection of wild type lumpy skin disease virus with beta-actin as internal amplification control. Molecular and Cellular Probes. 2021; 60: 101778. doi: 10.1016/j.mcp.2021.101778
10. Yang X, Yu F, Yan C, et al. Global trends in the application of droplet digital PCR technology in the field of infectious disease pathogen diagnosis: A bibliometric analysis from 2012 to 2023. Diagnostic Microbiology and Infectious Disease. 2025; 111(3): 116623. doi: 10.1016/j.diagmicrobio.2024.116623
11. Li W, Zhang S, Dang S, et al. Establishment of an A/T-Rich Specifically MGB Probe digital droplet PCR Assays Based on SNP for Brucella wild strains and vaccine strains. Diagnostic Microbiology and Infectious Disease. 2024; 110(1): 116432. doi: 10.1016/j.diagmicrobio.2024.116432
12. Singh R, Ramakrishna G, Sharma MK, et al. Droplet digital PCR technique is ultrasensitive for the quantification of covalently closed circular DNA in the blood of chronic HBV-infected patients. Clinics and Research in Hepatology and Gastroenterology. 2025; 49(3): 102531. doi: 10.1016/j.clinre.2025.102531
13. Fyfe JAM, Lavender CJ. Extraction of DNA from Environmental Samples for the Real-Time PCR Detection of Mycobacterium ulcerans. Methods in molecular biology. 2022; 2387: 63-69. doi: 10.1007/978-1-0716-1779-3_7
14. Bergallo M, Daprà V, Fava P, et al. Lack of detection of Cutavirus DNA using PCR real time in cutaneous T-cell lymphomas. Italian Journal of Dermatology and Venereology. 2021; 155(6). doi: 10.23736/s0392-0488.18.06161-8
15. Mota CA, Venazzi EAS, Zanzarini PD, et al. Filter paper performance in PCR for cutaneous leishmaniasis diagnosis. Journal of the Brazilian Society of Tropical Medicine. 2021; 54. doi: 10.1590/0037-8682-0047-2020
16. Belozerov KE, Avrusin IS, Andaryanova LI, et al. COVID-19 Associated Vasculitis Confirmed by the Tissues RT-PCR: A Case Series Report. Biomedicines. 2023; 11(3): 870. doi: 10.3390/biomedicines11030870
17. Kumar R, Chander Y, Verma A, et al. A novel HRM-based gap-qRT-PCR for identification and quantitation of the vaccine and field strain(s) of lumpy skin disease virus. Journal of Immunological Methods. 2023; 519: 113521. doi: 10.1016/j.jim.2023.113521
18. Tarján ZL, Doszpoly A, Eszterbauer E, et al. Partial genetic characterisation of a novel alloherpesvirus detected by PCR in a farmed wels catfish (Silurus glanis). Acta Veterinaria Hungarica. 2022; 70(4): 321-327. doi: 10.1556/004.2022.00038
19. Jevšnik M, Lusa L, Uršič T, et al. Detection of herpes simplex and varicella-zoster virus from skin lesions: comparison of RT-PCR and isothermal amplification for rapid identification. Diagnostic Microbiology and Infectious Disease. 2020; 97(2): 115015. doi: 10.1016/j.diagmicrobio.2020.115015
20. Camprodon Gómez M, González-Cruz C, Ferrer B, et al. Leucocytoclastic vasculitis in a patient with COVID-19 with positive SARS-CoV-2 PCR in skin biopsy. BMJ Case Reports. 2020; 13(10): e238039. doi: 10.1136/bcr-2020-238039
21. Wu X, Zhou X, Wang Y, et al. Development and validation of a droplet digital PCR method for quantifying lentiviral vector infectious titer. Heliyon. 2024; 10(20): e38512. doi: 10.1016/j.heliyon.2024.e38512
22. Wang H, Kong Y, Mei L, et al. Multiplex Real-Time PCR Method for Simultaneous Detection and Differentiation of Goat pox Virus, Sheeppox Virus, and Lumpy Skin Disease Virus. Journal of AOAC International. 2021; 104(5): 1389-1393. doi: 10.1093/jaoacint/qsab040
23. Barchitta M, Maugeri A, Campisi E, et al. Comparison of Quantitative Real-Time PCR and Digital PCR to Detect the Polyomavirus in Merkel Cell Carcinoma. Viruses. 2022; 14(10): 2195. doi: 10.3390/v14102195
24. Sun L, Wang C, Wu C, et al. Analysis of the Clinical Characteristics of Dipeptidyl Peptidase-4 Inhibitor–Induced Bullous Pemphigoid. Annals of Pharmacotherapy. 2021; 56(2): 205-212. doi: 10.1177/10600280211022722
25. Bishnoi A, De D, Handa S, Mahajan R. Biologics in autoimmune bullous diseases: Current scenario. Indian Journal of Dermatology, Venereology and Leprology. 2021; 87(5): 611-620. doi: 10.25259/IJDVL_886_19
26. Shih Y, Yuan H, Shen J, et al. BP230 IgE autoantibodies in topical‐steroid‐resistant bullous pemphigoid. The Journal of Dermatology. 2021; 48(9): 1372-1380. doi: 10.1111/1346-8138.15952
27. Li S, Xiang R, Jing K, et al. Diagnostic values of indirect immunofluorescence using salt-split skin, direct immunofluorescence and BP180 NC16A ELISA on bullous pemphigoid. Chinese Medical Journal. 2022; 135(11): 1379-1380. doi: 10.1097/cm9.0000000000002196
28. Wang LL, Moshiri AS, Novoa R, et al. Comparison of C3d immunohistochemical staining to enzyme-linked immunosorbent assay and immunofluorescence for diagnosis of bullous pemphigoid. Journal of the American Academy of Dermatology. 2020; 83(1): 172-178. doi: 10.1016/j.jaad.2020.02.020
29. Kawsar A, Edwards C, Patel P, et al. Checkpoint inhibitor-associated bullous cutaneous immune-related adverse events: a multicentre observational study. British Journal of Dermatology. 2022; 187(6): 981-987. doi: 10.1111/bjd.21836
30. Abdat R, Waldman RA, de Bedout V, et al. Dupilumab as a novel therapy for bullous pemphigoid: A multicenter case series. Journal of the American Academy of Dermatology. 2020; 83(1): 46-52. doi: 10.1016/j.jaad.2020.01.089
Copyright (c) 2025 Author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright on all articles published in this journal is retained by the author(s), while the author(s) grant the publisher as the original publisher to publish the article.
Articles published in this journal are licensed under a Creative Commons Attribution 4.0 International, which means they can be shared, adapted and distributed provided that the original published version is cited.
Submit a Paper
